| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e02ffa5f62a336caa3c4895675df7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b696e0f877a6265d44e3b69c767dcf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_329abc63bb83b3ae51a3d7b523b5896a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a79b5962bb3a1c3419a8ebc669af25c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3692a157f81c54aec3cdf0f2a02bbd8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cf27f5807af23a7ee72ce09c50d769a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c2b7d9e7fd41b2cab15fc4c4927c1b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56541df79a26070c6c2c585b54af47c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6da7997703ac3ca7e144878472384d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7fae3a757682444ebb075b2d54212f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee2eb287240fcdb70e49d4d65b9a167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85db1b7695d049550d6317e4dde50293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec58e8ce729667202b58ae04330bbeb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96db5c28f91de169b149ef21443143bf |
| publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012176796-A1 |
| titleOfInvention |
Method for amplifying nk cells |
| abstract |
A technique is developed to prepare the optimum number of NK cells for cell therapy by amplifying NK cells from collected blood cells in vitro. The present invention provides a method for amplifying NK cells. This method for amplifying NK cells includes a step for preparing a cell population containing NK cells, a step for removing T cells from this cell population containing NK cells, and a step for culturing the remaining cells from which the T cells have been removed in a medium containing 2500 IU/mL to 2813 IU/mL of IL-2. This method for amplifying NK cells sometimes includes a step for removing hematopoietic progenitor cells from the cell population containing NK cells. The present invention provides a pharmaceutical composition for cell therapy containing NK cells prepared by this method for amplifying NK cells. The pharmaceutical composition for cell therapy of the present invention is sometimes used to treat infections and/or cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018193303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018207900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723924-B2 |
| priorityDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |